Výsledky vyhledávání

Akademický článek

The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study.

Autor: Fujii H; Department of Pharmacy, Gifu University Hospital, Gifu, Japan., Tsuchiya M; Department of Pharmacy, Miyagi Cancer Center, Miyagi, Japan., Watanabe D; Department of Pharmacy, Gifu University Hospital, Gifu, Japan.; Innovative and Clinical Research Promotion Center, Gifu University Hospital, Gifu, Japan., Otsuka R; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan., Hirate D; Department of Pharmacy, Teine Keijinkai Hospital, Hokkaido, Japan., Takahashi K; Department of Pharmacy, Osaka City University Hospital, Osaka, Japan., Go M; Department of Pharmacy, Ogaki Municipal Hospital, Gifu, Japan., Kudo T; Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan., Shimomura K; Department of Pharmacy, Aichi Cancer Center Hospital, Aichi, Japan., Ando Y; Department of Pharmacotherapeutics and Informatics, Fujita Health University, Aichi, Japan., Tani S; First Department of Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan., Takahashi T; Department of Gastroenterological Surgery, Pediatric Surgery, Gifu University Graduate School of Medicine, Gifu, Japan.; Department of Surgery, Seino Kosei Hospital, Gifu Seino Medical Center, Gifu, Japan., Hayashi K; Department of Pharmacy, Miyagi Cancer Center, Miyagi, Japan., Chin M; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan., Matsunami N; Department of Pharmacy, Teine Keijinkai Hospital, Hokkaido, Japan., Takahashi M; Department of Pharmacy, Osaka City University Hospital, Osaka, Japan., Hasegawa A; Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan., Uchida T; Department of Pharmacy, Miyagi Cancer Center, Miyagi, Japan., Hashimoto H; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan., Kubo A; Department of Pharmacy, National Cancer Center Hospital, Tokyo, Japan., Matsuhashi N; Department of Gastroenterological Surgery, Pediatric Surgery, Gifu University Graduate School of Medicine, Gifu, Japan., Suzuki A; Department of Pharmacy, Gifu University Hospital, Gifu, Japan.; Laboratory of Advanced Medical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan., Nishimura J; Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan., Inui N; First Department of Medicine, Hamamatsu University School of Medicine, Shizuoka, Japan., Iihara H; Department of Pharmacy, Gifu University Hospital, Gifu, Japan. iihara.hirotoshi.p7@f.gifu-u.ac.jp.; Patient Safety Division, Gifu University Hospital, Gifu, Japan. iihara.hirotoshi.p7@f.gifu-u.ac.jp.; Laboratory of Community Pharmaceutical Practice and Science, Gifu Pharmaceutical University, Gifu, Japan. iihara.hirotoshi.p7@f.gifu-u.ac.jp.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Apr 17; Vol. 32 (5), pp. 291. Date of Electronic Publication: 2024 Apr 17.

Zobrazit plný text záznamu

Akademický článek

Registry study of immune-related adverse events using electronic patient-reported outcome in patients with cancer receiving immune checkpoint inhibitors: protocol for a multicentre cohort study.

Autor: Hirata T; Department of Pharmacy, Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, Japan., Kawaguchi T; Department of Practical Pharmacy, Tokyo University of Pharmacy and Life Sciences, Hachioji, Japan tkawa@toyaku.ac.jp.; Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan., Azuma K; Department of Pharmacy, Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, Japan., Torii A; Department of Pharmacy, Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, Japan., Usui H; Department of Pharmacy, Kyorin University Hospital, Mitaka, Japan., Kim S; Department of Pharmacy, Juntendo University Nerima Hospital, Nerima-ku, Japan., Hayama T; Department of Pharmacy, Nihon University Itabashi Hospital, Itabashi-ku, Japan., Hirate D; Department of Pharmacy, Teine Keijinkai Hospital, Sapporo, Japan., Kawahara Y; Department of Pharmacy, JR Tokyo General Hospital, Shibuya-ku, Japan., Kumihashi Y; Department of Pharmacy, Tokushima Red Cross Hospital, Komatsushima, Japan., Chisaka T; Department of Pharmacy, University of Miyazaki Hospital, Miyazaki-gun, Japan., Wako T; Department of Pharmacy, Nippon Medical School Hospital, Bunkyo-ku, Japan., Yoshimura A; Department of Clinical Oncology, Outpatient Chemotherapy Center, Tokyo Medical University Hospital, Shinjuku-ku, Tokyo, Japan., Miyaji T; Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan., Yamaguchi T; Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.

Publikováno v: BMJ open [BMJ Open] 2023 Nov 22; Vol. 13 (11), pp. e073724. Date of Electronic Publication: 2023 Nov 22.

Zobrazit plný text záznamu

Akademický článek

Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatment.

Autor: Saito Y; Department of Pharmacy, Hokkaido University Hospital, Kita 14-jo, Nishi 5-chome, Kita-ku, Sapporo, 060-8648, Japan.; Department of Clinical Pharmaceutics & Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, 4-1, Maeda 7-jo 15-chome, Teine-ku, Sapporo, 006-8585, Japan., Tamaki S; Department of Pharmacy, KKR Sapporo Medical Center, 3-40, Hiragishi 1-jo 6-chome, Toyohira-ku, Sapporo, 062-0931, Japan., Hirate D; Department of Pharmacy, Teine Keijinkai Hospital, 1-40, Maeda 1-jo 12-chome, Teine-ku, Sapporo, 006-8555, Japan., Takada S; Department of Pharmacy, National Hospital Organization Hokkaido Cancer Center, 3-4 Kikusui, Shiroishi-ku, Sapporo, 003-0804, Japan., Takahashi K; Department of Pharmacy, NTT Medical Center Sapporo, Minami 1-jo, Nishi 15-chome, Tyuou-ku, Sapporo, 060-0061, Japan., Takekuma Y; Department of Pharmacy, Hokkaido University Hospital, Kita 14-jo, Nishi 5-chome, Kita-ku, Sapporo, 060-8648, Japan., Sakakibara-Konishi J; Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Kita 15-jo, Nishi 7-chome, Kita-ku, Sapporo, 060-8638, Japan., Shimizu Y; Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15-jo, Nishi 7-chome, Kita-ku, Sapporo, 060-8638, Japan., Kinoshita I; Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15-jo, Nishi 7-chome, Kita-ku, Sapporo, 060-8638, Japan., Sugawara M; Department of Pharmacy, Hokkaido University Hospital, Kita 14-jo, Nishi 5-chome, Kita-ku, Sapporo, 060-8648, Japan. msuga@med.hokudai.ac.jp.; Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12-jo, Nishi 6-chome, Kita-ku, Sapporo, 060-0812, Japan. msuga@med.hokudai.ac.jp.

Publikováno v: Scientific reports [Sci Rep] 2023 Nov 09; Vol. 13 (1), pp. 19457. Date of Electronic Publication: 2023 Nov 09.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients.

Autor: Saito Y; Department of Clinical Pharmaceutics & Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, 4-1, Maeda 7-Jo 15-Chome, Teine-Ku, Sapporo, 006-8585, Japan. saito-yo@hus.ac.jp.; Department of Pharmacy, Hokkaido University Hospital, Kita 14-Jo, Nishi 5-Chome, Kita-Ku, Sapporo, 060-8648, Japan. saito-yo@hus.ac.jp., Kobayashi M; Laboratory of Clinical Pharmaceutics & Therapeutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12-Jo, Nishi 6-Chome, Kita-Ku, Sapporo, 060-0812, Japan., Tamaki S; Department of Pharmacy, KKR Sapporo Medical Center, 3-40, Hiragishi 1-Jo 6-Chome, Toyohira-Ku, Sapporo, 062-0931, Japan., Nakamura K; Division of Hospital Pharmacy, Sapporo Medical University, 291, Minami 1-Jo, Nishi 16-Chome, Chuo-Ku, Sapporo, 060-8543, Japan., Hirate D; Department of Pharmacy, Teine Keijinkai Hospital, 1-40, Maeda 1-Jo 12-Chome, Teine-Ku, Sapporo, 006-8555, Japan., Takahashi K; Department of Pharmacy, NTT Medical Center Sapporo, Minami 1-Jo, Nishi 15-Chome, Chuo-Ku, Sapporo, 060-0061, Japan., Takekuma Y; Department of Pharmacy, Hokkaido University Hospital, Kita 14-Jo, Nishi 5-Chome, Kita-Ku, Sapporo, 060-8648, Japan., Sakakibara-Konishi J; Department of Respiratory Medicine, Faculty of Medicine, Hokkaido University, Kita 15-Jo, Nishi 7-Chome, Kita-Ku, Sapporo, 060-8638, Japan., Shimizu Y; Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15-Jo, Nishi 7-Chome, Kita-Ku, Sapporo, 060-8638, Japan., Kinoshita I; Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita 15-Jo, Nishi 7-Chome, Kita-Ku, Sapporo, 060-8638, Japan., Sugawara M; Department of Pharmacy, Hokkaido University Hospital, Kita 14-Jo, Nishi 5-Chome, Kita-Ku, Sapporo, 060-8648, Japan.; Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University, Kita 12-Jo, Nishi 6-Chome, Kita-Ku, Sapporo, 060-0812, Japan.

Publikováno v: Scientific reports [Sci Rep] 2023 Oct 10; Vol. 13 (1), pp. 17126. Date of Electronic Publication: 2023 Oct 10.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vyhledávací nástroje:

Upřesnit hledání